Autologous (self) mononuclear cells derived from umbilical cord blood
18-004753
Phase 2 mab active
Quick answer
Autologous (self) mononuclear cells derived from umbilical cord blood for Hypoplastic Left Heart Syndrome is a Phase 2 program (mab) at Regen BioPharma Inc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regen BioPharma Inc
- Indication
- Hypoplastic Left Heart Syndrome
- Phase
- Phase 2
- Modality
- mab
- Status
- active